🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 02/03/1989 | 0,0652 USD |
| 29/11/1988 | 0,0588 USD |
| 29/08/1988 | 0,0469 USD |
| 03/06/1988 | 0,0509 USD |
| 29/02/1988 | 0,0509 USD |
| 01/12/1987 | 0,0424 USD |
| 28/08/1987 | 0,0424 USD |
| 02/06/1987 | 0,0292 USD |
| 02/03/1987 | 0,0292 USD |
| 02/12/1986 | 0,0292 USD |
| 02/09/1986 | 0,0292 USD |
| 03/06/1986 | 0,0239 USD |
| 27/02/1986 | 0,0239 USD |
| 03/12/1985 | 0,0239 USD |
| 30/08/1985 | 0,0212 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 09/08/1973 | 2,39 | 2,39 | 2,37 | 2,38 | -0,28% | 0,83% | 1.852.445 |
| 08/08/1973 | 2,39 | 2,39 | 2,38 | 2,39 | -0,55% | 0,69% | 747.014 |
| 07/08/1973 | 2,39 | 2,41 | 2,39 | 2,40 | +0,83% | 0,97% | 958.291 |
| 06/08/1973 | 2,39 | 2,40 | 2,37 | 2,38 | -0,55% | 1,25% | 879.062 |
| 03/08/1973 | 2,41 | 2,41 | 2,37 | 2,39 | -0,83% | 1,79% | 494.237 |
| 02/08/1973 | 2,41 | 2,42 | 2,39 | 2,41 | +0,00% | 1,10% | 418.781 |
| 01/08/1973 | 2,44 | 2,44 | 2,40 | 2,41 | -2,15% | 1,63% | 630.058 |
| 31/07/1973 | 2,46 | 2,47 | 2,45 | 2,47 | +0,13% | 0,81% | 1.154.477 |
| 30/07/1973 | 2,47 | 2,48 | 2,45 | 2,46 | -0,13% | 1,21% | 1.112.976 |
| 27/07/1973 | 2,43 | 2,47 | 2,42 | 2,47 | +1,36% | 1,91% | 980.928 |
| 26/07/1973 | 2,43 | 2,47 | 2,42 | 2,43 | +0,14% | 2,32% | 1.924.128 |
| 25/07/1973 | 2,37 | 2,43 | 2,37 | 2,43 | +2,52% | 2,38% | 2.056.176 |
| 24/07/1973 | 2,35 | 2,37 | 2,35 | 2,37 | +0,70% | 0,99% | 1.792.080 |
| 23/07/1973 | 2,38 | 2,39 | 2,32 | 2,35 | -0,98% | 2,93% | 1.350.662 |
| 20/07/1973 | 2,35 | 2,38 | 2,35 | 2,38 | +0,99% | 1,13% | 1.048.838 |
| 19/07/1973 | 2,35 | 2,38 | 2,34 | 2,35 | +0,29% | 1,70% | 1.361.981 |
| 18/07/1973 | 2,36 | 2,37 | 2,34 | 2,35 | -0,56% | 1,12% | 1.380.845 |
| 17/07/1973 | 2,34 | 2,37 | 2,34 | 2,36 | +2,30% | 1,42% | 1.097.885 |
| 16/07/1973 | 2,25 | 2,31 | 2,23 | 2,31 | +2,66% | 3,25% | 1.316.707 |
| 13/07/1973 | 2,26 | 2,26 | 2,23 | 2,25 | -0,88% | 1,46% | 3.029.558 |
| 12/07/1973 | 2,28 | 2,29 | 2,24 | 2,27 | -0,58% | 1,89% | 1.184.659 |
| 11/07/1973 | 2,23 | 2,28 | 2,23 | 2,28 | +3,15% | 2,38% | 3.086.150 |
| 10/07/1973 | 2,21 | 2,23 | 2,18 | 2,21 | +0,00% | 2,10% | 1.478.938 |
| 09/07/1973 | 2,21 | 2,21 | 2,16 | 2,21 | +0,15% | 2,10% | 1.478.938 |
| 06/07/1973 | 2,25 | 2,25 | 2,21 | 2,21 | -2,06% | 1,77% | 2.025.994 |
| 05/07/1973 | 2,28 | 2,28 | 2,23 | 2,25 | -2,30% | 2,33% | 2.456.093 |
| 03/07/1973 | 2,36 | 2,36 | 2,29 | 2,31 | -3,20% | 2,95% | 765.878 |
| 02/07/1973 | 2,38 | 2,38 | 2,37 | 2,38 | +0,00% | 0,42% | 1.282.752 |
| 29/06/1973 | 2,41 | 2,41 | 2,38 | 2,38 | -1,10% | 1,10% | 1.014.883 |
| 28/06/1973 | 2,37 | 2,41 | 2,37 | 2,41 | +1,54% | 1,54% | 1.301.616 |